Evidence map›Paper›PMID 21960726›Full record

ReviewCirculation research2011

Role of cardiac stem cells in cardiac pathophysiology: a paradigm shift in human myocardial biology.

Annarosa Leri, Jan Kajstura, Piero Anversa

RetractedAbstract readReviewRetracted Publication
In one paragraph

Review in Circulation research, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It has been retracted, and should not be counted. Cited by 93 papers.

0numbers the graph read from it
0cells of the map it votes in
93citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

93 citing papers in PubMed.

  1. Trial
  2. Trial
  3. Review
  4. Cell Therapy in the Treatment of Coronary Heart Disease.International journal of molecular sciences · 2023
    Review
  5. The Role of Nitric Oxide in Stem Cell Biology.Antioxidants (Basel, Switzerland) · 2022
    Review
  6. Article
  7. Article
  8. Bradykinin-mediated CaJournal of cellular and molecular medicine · 2018
    Article
  9. Review
  10. Article
  11. Review
  12. Review
  13. Article
  14. Article
  15. Article
  16. Pim1 Kinase Overexpression Enhances ckitJournal of the American College of Cardiology · 2016
    Article
  17. Review
  18. Review
  19. Article
  20. Article

33 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

3 authors.

Annarosa LeriDepartments of Anesthesia and Medicine, and Division of Cardiovascular Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA 02115, USA.
Jan Kajstura
Piero Anversa

Funding

Rebuilding the Failing HeartP01HL092868 · NHLBI · BRIGHAM AND WOMEN'S HOSPITAL · PI ANVERSA, PIERO · 2008 to 2013
$12.9M
Repair and Angiogenesis by Stem Cells in Human HeartR37HL081737 · NHLBI · NEW YORK MEDICAL COLLEGE · PI ANVERSA, PIERO · 2005 to 2015
$6.5M
IGF-1, Gender, Heart Failure and Longevity: A Paradigm ShiftR01AG017042 · NIA · NEW YORK MEDICAL COLLEGE · PI ANVERSA, PIERO · 2000 to 2010
$5.3M
Coronary Vasculature Progenitor Cell in Human Ischemic Heart FailureR01HL039902 · NHLBI · NEW YORK UNIVERSITY · PI ANVERSA, PIERO, KAJSTURA, JAN · 1989 to 2012
$4.7M
MYOCYTE STEM CELLS IN THE MAMMALIAN HEARTR01HL065577 · NHLBI · NEW YORK MEDICAL COLLEGE · PI LERI, ANNAROSA · 2000 to 2012
$2.9M
Redefining Human Myocardial BiologyR01HL105532 · NHLBI · BRIGHAM AND WOMEN'S HOSPITAL · PI ANVERSA, PIERO, BUCHHOLZ, BRUCE A · 2011 to 2014
$2.2M
IGF-1 and Diabetic HeartR01HL065573 · NHLBI · NEW YORK MEDICAL COLLEGE · PI KAJSTURA, JAN · 2001 to 2010
$2.1M
Immortal DNA Strand and Cardiac Stem Cell AgingR01AG037495 · NIA · BRIGHAM AND WOMEN'S HOSPITAL · PI ANVERSA, PIERO · 2011 to 2014
$2.0M
Cardiac Stem Cell Growth, Aging and DeathR01HL075480 · NHLBI · NEW YORK MEDICAL COLLEGE · PI KAJSTURA, JAN · 2004 to 2008
$1.9M
Telomeric Shortening, p53 and miR-34a Condition Senescence of Cardiac ProgenitorsR01AG037490 · NIA · BRIGHAM AND WOMEN'S HOSPITAL · PI LERI, ANNAROSA · 2010 to 2014
$1.7M
Cardiomyogenesis in the Adult HeartR01HL114346 · NHLBI · BRIGHAM AND WOMEN'S HOSPITAL · PI LERI, ANNAROSA, ROTA, MARCELLO · 2012 to 2015
$1.7M
Cardiac Stem Cells and AngiomyogenesisR01HL111183 · NHLBI · BRIGHAM AND WOMEN'S HOSPITAL · PI LERI, ANNAROSA · 2012 to 2015
$1.7M
NHLBI NIH HHS P01 HL092868NHLBI NIH HHS R01 HL039902NHLBI NIH HHS R01 HL065573NHLBI NIH HHS R01 HL065577NHLBI NIH HHS R01 HL075480NHLBI NIH HHS R01 HL105532NHLBI NIH HHS R01 HL111183NHLBI NIH HHS R01 HL114346NHLBI NIH HHS R37 HL081737NIA NIH HHS R01 AG017042NIA NIH HHS R01 AG026107NIA NIH HHS R01 AG037490NIA NIH HHS R01 AG037495
6 · The paper itself

Abstract

For nearly a century, the human heart has been viewed as a terminally differentiated postmitotic organ in which the number of cardiomyocytes is established at birth, and these cells persist throughout the lifespan of the organ and organism. However, the discovery that cardiac stem cells live in the heart and differentiate into the various cardiac cell lineages has changed profoundly our understanding of myocardial biology. Cardiac stem cells regulate myocyte turnover and condition myocardial recovery after injury. This novel information imposes a reconsideration of the mechanisms involved in myocardial aging and the progression of cardiac hypertrophy to heart failure. Similarly, the processes implicated in the adaptation of the infarcted heart have to be dissected in terms of the critical role that cardiac stem cells and myocyte regeneration play in the restoration of myocardial mass and ventricular function. Several categories of cardiac progenitors have been described but, thus far, the c-kit-positive cell is the only class of resident cells with the biological and functional properties of tissue specific adult stem cells.

Indexed as

Adult Stem CellsAnimalsCell DifferentiationCell EnlargementHeart DiseasesHumansMyocardiumMyocytes, CardiacStem Cells

Identifiers

PMID21960726
PMCPMC3299091

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.